Report Detail
Global Nuclear Medicine Market Growth 2019-2024
- RnM2975446 |
- 18 February, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
According to this study, over the next five years the Nuclear Medicine market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 6610 million by 2024, from US$ 4590 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nuclear Medicine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine market by product type, application, key manufacturers and key regions and countries.
This study considers the Nuclear Medicine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Diagnostic
Therapeutic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nuclear Medicine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nuclear Medicine market by identifying its various subsegments.
Focuses on the key global Nuclear Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nuclear Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Nuclear Medicine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nuclear Medicine Consumption 2014-2024
- 2.1.2 Nuclear Medicine Consumption CAGR by Region
- 2.2 Nuclear Medicine Segment by Type
- 2.2.1 Tc-99
- 2.2.2 I-123/131
- 2.2.3 In-111
- 2.2.4 Xe-133
- 2.2.5 Th-201
- 2.2.6 Ga-67
- 2.2.7 Other
- 2.3 Nuclear Medicine Consumption by Type
- 2.3.1 Global Nuclear Medicine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Nuclear Medicine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Nuclear Medicine Sale Price by Type (2014-2019)
- 2.4 Nuclear Medicine Segment by Application
- 2.4.1 Diagnostic
- 2.4.2 Therapeutic
- 2.5 Nuclear Medicine Consumption by Application
- 2.5.1 Global Nuclear Medicine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Nuclear Medicine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Nuclear Medicine Sale Price by Application (2014-2019)
3 Global Nuclear Medicine by Players
- 3.1 Global Nuclear Medicine Sales Market Share by Players
- 3.1.1 Global Nuclear Medicine Sales by Players (2017-2019)
- 3.1.2 Global Nuclear Medicine Sales Market Share by Players (2017-2019)
- 3.2 Global Nuclear Medicine Revenue Market Share by Players
- 3.2.1 Global Nuclear Medicine Revenue by Players (2017-2019)
- 3.2.2 Global Nuclear Medicine Revenue Market Share by Players (2017-2019)
- 3.3 Global Nuclear Medicine Sale Price by Players
- 3.4 Global Nuclear Medicine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Nuclear Medicine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Nuclear Medicine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Nuclear Medicine by Regions
- 4.1 Nuclear Medicine by Regions
- 4.1.1 Global Nuclear Medicine Consumption by Regions
- 4.1.2 Global Nuclear Medicine Value by Regions
- 4.2 Americas Nuclear Medicine Consumption Growth
- 4.3 APAC Nuclear Medicine Consumption Growth
- 4.4 Europe Nuclear Medicine Consumption Growth
- 4.5 Middle East & Africa Nuclear Medicine Consumption Growth
5 Americas
- 5.1 Americas Nuclear Medicine Consumption by Countries
- 5.1.1 Americas Nuclear Medicine Consumption by Countries (2014-2019)
- 5.1.2 Americas Nuclear Medicine Value by Countries (2014-2019)
- 5.2 Americas Nuclear Medicine Consumption by Type
- 5.3 Americas Nuclear Medicine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Nuclear Medicine Consumption by Countries
- 6.1.1 APAC Nuclear Medicine Consumption by Countries (2014-2019)
- 6.1.2 APAC Nuclear Medicine Value by Countries (2014-2019)
- 6.2 APAC Nuclear Medicine Consumption by Type
- 6.3 APAC Nuclear Medicine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Nuclear Medicine by Countries
- 7.1.1 Europe Nuclear Medicine Consumption by Countries (2014-2019)
- 7.1.2 Europe Nuclear Medicine Value by Countries (2014-2019)
- 7.2 Europe Nuclear Medicine Consumption by Type
- 7.3 Europe Nuclear Medicine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Nuclear Medicine by Countries
- 8.1.1 Middle East & Africa Nuclear Medicine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Nuclear Medicine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Nuclear Medicine Consumption by Type
- 8.3 Middle East & Africa Nuclear Medicine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Nuclear Medicine Distributors
- 10.3 Nuclear Medicine Customer
11 Global Nuclear Medicine Market Forecast
- 11.1 Global Nuclear Medicine Consumption Forecast (2019-2024)
- 11.2 Global Nuclear Medicine Forecast by Regions
- 11.2.1 Global Nuclear Medicine Forecast by Regions (2019-2024)
- 11.2.2 Global Nuclear Medicine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Nuclear Medicine Forecast by Type
- 11.8 Global Nuclear Medicine Forecast by Application
12 Key Players Analysis
- 12.1 GE Healthcare
- 12.1.1 Company Details
- 12.1.2 Nuclear Medicine Product Offered
- 12.1.3 GE Healthcare Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GE Healthcare News
- 12.2 Bracco Imaging
- 12.2.1 Company Details
- 12.2.2 Nuclear Medicine Product Offered
- 12.2.3 Bracco Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bracco Imaging News
- 12.3 Mallinckrodt
- 12.3.1 Company Details
- 12.3.2 Nuclear Medicine Product Offered
- 12.3.3 Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Mallinckrodt News
- 12.4 Lantheus Medical Imaging
- 12.4.1 Company Details
- 12.4.2 Nuclear Medicine Product Offered
- 12.4.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Lantheus Medical Imaging News
- 12.5 Bayer
- 12.5.1 Company Details
- 12.5.2 Nuclear Medicine Product Offered
- 12.5.3 Bayer Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Bayer News
- 12.6 Triad Isotopes
- 12.6.1 Company Details
- 12.6.2 Nuclear Medicine Product Offered
- 12.6.3 Triad Isotopes Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Triad Isotopes News
- 12.7 Nordion
- 12.7.1 Company Details
- 12.7.2 Nuclear Medicine Product Offered
- 12.7.3 Nordion Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Nordion News
- 12.8 Jubilant Pharma
- 12.8.1 Company Details
- 12.8.2 Nuclear Medicine Product Offered
- 12.8.3 Jubilant Pharma Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Jubilant Pharma News
- 12.9 Eli Lilly
- 12.9.1 Company Details
- 12.9.2 Nuclear Medicine Product Offered
- 12.9.3 Eli Lilly Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Eli Lilly News
- 12.10 SIEMENS
- 12.10.1 Company Details
- 12.10.2 Nuclear Medicine Product Offered
- 12.10.3 SIEMENS Nuclear Medicine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 SIEMENS News
- 12.11 China Isotope & Radiation
- 12.12 Dongcheng
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nuclear Medicine . Industry analysis & Market Report on Nuclear Medicine is a syndicated market report, published as Global Nuclear Medicine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
